Copyright
©The Author(s) 2020.
World J Hepatol. Nov 27, 2020; 12(11): 1046-1054
Published online Nov 27, 2020. doi: 10.4254/wjh.v12.i11.1046
Published online Nov 27, 2020. doi: 10.4254/wjh.v12.i11.1046
Table 3 The rates of patients whose alpha-fetoprotein and PIVKA-II showed normal values in those whose maximum tumor size was ≤ 2 cm, n = 394 cases
| HCC tumor marker | No. of cases (%) |
| AFP, normal cases | 199 (50.5) |
| PIVKA-II, normal cases | 271 (68.8) |
| Both AFP and PIVKA-II, normal cases | 142 (36.4) |
- Citation: Tarao K, Nozaki A, Komatsu H, Komatsu T, Taguri M, Tanaka K, Chuma M, Numata K, Maeda S. Real impact of tumor marker AFP and PIVKA-II in detecting very small hepatocellular carcinoma (≤ 2 cm, Barcelona stage 0) - assessment with large number of cases. World J Hepatol 2020; 12(11): 1046-1054
- URL: https://www.wjgnet.com/1948-5182/full/v12/i11/1046.htm
- DOI: https://dx.doi.org/10.4254/wjh.v12.i11.1046